Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Warburgia salutaris leaf extract is a research-stage botanical extract derived from the leaves of the pepper-bark tree (*Warburgia salutaris*), a plant native to Southern Africa with a history of traditional medicinal use. Academic research has primarily investigated the extract's potential anticancer properties, particularly against MCF-7 breast cancer cells, where it demonstrates antiproliferative and pro-apoptotic effects. Mechanistically, the extract appears to induce DNA damage and trigger the intrinsic apoptotic pathway, characterized by the upregulation of pro-apoptotic Bax and Caspase-3, alongside the downregulation of anti-apoptotic Bcl-2. Additionally, the extract has been studied for its traditional applications, which include anti-inflammatory, antimicrobial, and antimalarial activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Warburgia salutaris leaf extract.